What is the treatment for Group B streptococcus (GBS) in urine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Group B Streptococcus in Urine

The treatment for Group B streptococcus (GBS) in urine depends on colony count and pregnancy status, with penicillin G being the first-line therapy for most GBS infections. 1

Asymptomatic GBS Bacteriuria

During Pregnancy

  • Women with GBS bacteriuria during pregnancy (regardless of colony count) should receive intrapartum antibiotic prophylaxis (IAP) at the time of labor or rupture of membranes to prevent early-onset neonatal GBS disease. 1, 2
  • For significant bacteriuria (≥100,000 CFU/mL), treatment at the time of detection is recommended 2
  • For low colony counts (<100,000 CFU/mL), immediate antibiotic treatment is not recommended for prevention of adverse outcomes such as pyelonephritis, chorioamnionitis, or preterm birth 2
  • Women with documented GBS bacteriuria should not be re-screened in the third trimester as they are presumed to be GBS colonized 2

Non-Pregnant Adults

  • Asymptomatic GBS colonization generally does not require treatment 1
  • Routine antibiotic treatment of asymptomatic carriers is not recommended except in specific situations (e.g., pregnancy) 1

Symptomatic GBS Urinary Tract Infection

First-Line Treatment

  • Penicillin G is the first-line therapy for most GBS infections 1
    • Recommended dose: 5 million units IV initial dose, followed by 2.5-3.0 million units IV every 4 hours until delivery (in pregnancy) 1
  • For non-pregnant patients with UTI symptoms, treatment should be based on susceptibility testing

Alternative Antibiotics (for penicillin allergy)

  • Ampicillin: 2 g IV initial dose, then 1 g IV every 4 hours 1
  • Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours 1
  • For true penicillin allergy: Erythromycin or clindamycin (if susceptible) 3
  • For UTI specifically: Nitrofurantoin is effective against GBS and has been recommended for GBS bacteriuria 4

Special Considerations

Antibiotic Resistance

  • While all GBS isolates remain sensitive to penicillin, some studies have shown intermediate or decreased sensitivity in 15% of isolates 4
  • Resistance rates for other antibiotics:
    • Azithromycin and ceftriaxone: 31%
    • Clindamycin: 19%
    • Cefazolin: 15%
    • Cefamandole: 13% 4

Pregnancy-Specific Management

  • Women with GBS in urine during pregnancy should receive IAP at delivery, independent of the colony count 5
  • The optimal IAP should be administered for at least 4 hours before delivery, though even 2 hours of antibiotic exposure reduces GBS vaginal colony counts 1
  • Penicillin allergy testing has been shown to be safe in pregnancy 5

Management of GBS Bacteremia (if UTI leads to bloodstream infection)

  • Evaluate for signs of sepsis and assess for potential sources of infection 1
  • Consider risk factors for severe infection (immunocompromise, diabetes, liver disease) 1
  • Remove infected catheters if present 1
  • Obtain follow-up blood cultures to document clearance of bacteremia 1

Important Caveats

  • For pregnant women with GBS bacteriuria, antibiotic sensitivities should be determined, especially if penicillin allergy is present 4
  • The greatest risk associated with penicillin therapy is anaphylactic reaction, with an estimated frequency of about 5 cases per 10,000 treatments 3
  • The dosing interval for penicillin G should be 4 hours to ensure anti-GBS activity in all patients; more frequent dosing does not increase activity 6

References

Guideline

Treatment of Small Intestinal Bacterial Overgrowth and Group B Streptococcus Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of group B streptococcal bacteriuria in pregnancy.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2012

Research

Antibiotic resistance patterns of group B streptococcal clinical isolates.

Infectious diseases in obstetrics and gynecology, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.